Migdal Insurance & Financial Holdings’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-82	Closed	-$75K	–	781
2018 Q3	$75K	Buy	82 +51	+165%	+$46.6K	﹤0.01%	623
2018 Q2	$23K	Buy	31 +30	+3,000%	+$22.3K	﹤0.01%	710
2018 Q1	$2K	Buy	+1	New	+$2K	﹤0.01%	614